Download Full Text (616 KB)


  • Advances in Pulmonary Medicine Facilitate Cancer Diagnosis, Treatment: The lungs present unique challenges in cancer diagnosis and treatment-navigating a maze of bronchi to find and sample tissue that will lead to an accurate diagnosis of lung cancer, for example, or deciding whether to proceed with treatment for cancer in the presence of concomitant lung disease
  • New Drugs Increase Treatment Options for Patients with Imatinib-Resistant Chronic Myeloid Leukemia: In the past year, several new targeted drugs have been approved as second-line treatments for imatinib-resistant chronic myeloid leukemia (CML). These drugs include the second-generation tyrosine kinase inhibitor bosutinib and the third-generation tyrosine kinase inhibitor ponatinib, which may change the standard of care for CML
  • Program Offers Physicians Courses on Treating Cancer Patients and Survivors: A series of courses available online enables physicians at The University of Texas MD Anderson Cancer Center to share with a global medical audience lessons learned from treating a high volume of patients at a tertiary cancer center
  • HOUSE CALL: Managing the Financial Burden of Long-Term Illness-Help is available for many patients

Publication Date



The University of Texas MD Anderson Cancer Center


Houston, Texas


History of Science, Technology, and Medicine | Oncology

Conditions Governing Access


OncoLog, Volume 58, Number 03, March 2013